Hansen-Hagge T E, Trefzer U, zu Reventlow A S, Kaltoft K, Sterry W
Humboldt University, Medical Faculty - Charité, Department of Dermatology and Allergy, Schumannstrasse 20/21, D-10117 Berlin, Germany and Institute of Human Genetics, University of Aarhus, 8000 C Aarhus, Denmark.
Nucleic Acids Res. 2001 Feb 15;29(4):E20. doi: 10.1093/nar/29.4.e20.
The representational difference analysis (RDA) and other subtraction techniques are used to enrich sample-specific sequences by elimination of ubiquitous sequences existing in both the sample of interest (tester) and the subtraction partner (driver). While applying the RDA to genomic DNA of cutaneous lymphoma cells in order to identify tumor relevant alterations, we predominantly isolated repetitive sequences and artificial repeat-mediated fusion products of otherwise independent PCR fragments (PCR hybrids). Since these products severely interfered with the isolation of tester-specific fragments, we developed a considerably more robust and efficient approach, termed ligation-mediated subtraction (Limes). In first applications of Limes, genomic sequences and/or transcripts of genes involved in the regulation of transcription, such as transforming growth factor beta stimulated clone 22 related gene (TSC-22R), cell death and cytokine production (caspase-1) or antigen presentation (HLA class II sequences), were found to be completely absent in a cutaneous lymphoma line. On the assumption that mutations in tumor-relevant genes can affect their transcription pattern, a protocol was developed and successfully applied that allows the identification of such sequences. Due to these results, Limes may substitute/supplement other subtraction/comparison techniques such as RDA or DNA microarray techniques in a variety of different research fields.
代表性差异分析(RDA)及其他消减技术通过去除目标样本(测试样本)和消减配对样本(驱动样本)中均存在的普遍序列,来富集样本特异性序列。在将RDA应用于皮肤淋巴瘤细胞的基因组DNA以鉴定肿瘤相关改变时,我们主要分离出了重复序列以及原本独立的PCR片段(PCR杂交体)的人工重复介导融合产物。由于这些产物严重干扰了测试样本特异性片段的分离,我们开发了一种更为稳健高效的方法,称为连接介导消减法(Limes)。在Limes的首次应用中,发现皮肤淋巴瘤细胞系中完全不存在参与转录调控的基因的基因组序列和/或转录本,如转化生长因子β刺激克隆22相关基因(TSC - 22R)、细胞死亡和细胞因子产生(半胱天冬酶 - 1)或抗原呈递(HLA II类序列)相关的基因。基于肿瘤相关基因突变会影响其转录模式这一假设,我们开发并成功应用了一种方案,可用于鉴定此类序列。基于这些结果,Limes在各种不同研究领域中可能会替代/补充其他消减/比较技术,如RDA或DNA微阵列技术。